{
  "id": 15599350,
  "title": "The future of medicine may depend on African DNA",
  "url": "https://urgent.news/2026/10/19/the-future-of-medicine-may-depend-on-african-dna",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-19T11:33:43.000Z",
  "source": {
    "name": "Semafor",
    "slug": "semafor",
    "url": "https://www.semafor.com/article/10/19/2026/the-future-of-medicine-may-depend-on-african-dna"
  },
  "original_language": "en",
  "account": "The future of medicine may depend on African DNA, as researchers recognize the importance of including diverse genetic backgrounds in genomic studies. Current precision medicine and genetic therapies do not work equally well for everyone, and this disparity is partly due to the underrepresentation of people of African ancestry in genomic datasets. To address this issue, an initial investment of $100 million over 10 years is proposed to create a coordinated, African-led genomics initiative. This effort would involve African governments, international funders, and life sciences companies working together to build the necessary infrastructure, including research institutions, biobanks, and bioinformatics capacity. This investment is considered worthwhile, as studying genetic variation in African ancestry populations has already led to significant discoveries, such as the identification of naturally occurring variants in the PCSK9 protein, which contribute to lower cholesterol and reduced coronary heart disease risk. These findings have paved the way for the development of PCSK9 inhibitors, a new class of cholesterol-lowering medicines now used worldwide. The discovery of such genetic differences in African populations has the potential to reveal new biological pathways that could lead to groundbreaking treatments. However, current genetic risk prediction tools, primarily developed using European-ancestry data, may be less accurate when applied to people with different genetic backgrounds. To ensure fair and reliable results in genomic medicine, sustained investment in Africa's ecosystem is crucial. This includes long-term support for African-led programs, meaningful involvement of communities in data usage and benefit-sharing, and sustained support from African governments, international funders, and pharmaceutical and biotechnology companies. This approach not only strengthens African health systems but also has the potential to bring scientific gains beyond the continent, ultimately leading to a better understanding of disease and the development of medicines that work for more people worldwide.",
  "summary": "A $100 million investment over the next decade could help African scientists unlock discoveries that improve medicine worldwide.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}